Inflammation Research

, Volume 60, Issue 8, pp 759–767 | Cite as

Mimic peptides bonding specifically with the first and second extracellular loops of the CC chemokine receptor 5 derived from a phage display peptide library are potent inhibitors of experimental autoimmune encephalomyelitis

  • Hui-min Zheng
  • Yun Jiang
  • Ju-rong Wang
  • Xue-lian Gong
  • Bao-yu Guo
Original Research Paper



To obtain mimic peptides that specifically bind with the first and second extracellular loops (ECL1, ECL2) of the CC chemokine receptor 5 (CCR5) and to study their treatment effects on experimental autoimmune encephalomyelitis (EAE) mice.


A phage display peptide library was applied to screen peptides that bond with ECL1 and ECL2. ELISA and DNA sequence analysis were used to identify positive clones. EAE mice were treated with synthesized peptides by intraperitoneal injection.


Eighteen positive clones were obtained and four peptides with sequences STFTTTL, TPIPQLL, SLPLPKP and QTSSAAL were identified. These peptides could significantly protect against and reduce the severity of EAE. The infiltration of monocytes and lymphocytes into the spinal cord decreased significantly in treated mice, while abundant inflammatory cells and demyelination were observed in spinal cords of EAE mice.


CCR5 mimic peptides provided a significant protective effect to EAE mice. These potent inhibitory mimic peptides could be useful in the clinical treatment of multiple sclerosis.


CCR5 Mimic peptides EAE 


  1. 1.
    Vyroubalova EC, Hartley O, Mermod N, Fisch I. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling. J Mol Immunol. 2006;43:1573–8.CrossRefGoogle Scholar
  2. 2.
    Wang FY, Zhang TY, Luo JX, He GA, Gu QL, Xiao F. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library. Biosci Biotechnol Biochem. 2006;70:2035–41.PubMedCrossRefGoogle Scholar
  3. 3.
    Hamann I, Zipp F, Duarte CI. Therapeutic targeting of chemokine signaling in multiple sclerosis. J Neurol Sci. 2008;27:431–8.Google Scholar
  4. 4.
    Ramnarine E, Devico AL, Vigil-Cruz SC. A synthetic peptide fragment derived from RANTES is a potent inhibitor of HIV-1 infectivity despite a surprising lack of CCR5 receptor affinity. Int J Pept Res Ther. 2004;10:637–43.CrossRefGoogle Scholar
  5. 5.
    Hofstetter HH, Karulin AY, Forsthuber TG, Ott PA, Lehmann TM, Lehmann PV. The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice. J Neuroimmunol. 2005;170:105–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Sajad M, Zargan J, Chawla R. Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol Cell Biochem. 2009;328:183–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Iskra EB, Jastrzebska IK, Joniec I. MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice. Inflamm Res. 2007;56:311–7.CrossRefGoogle Scholar
  8. 8.
    Kennedy KJ, Karpus WJ. Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis. J Clin Immunol. 1999;19:273–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Li XB, Schluesener HJ. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis. Arch Immunol Ther Exp. 2006;54:51–3.CrossRefGoogle Scholar
  10. 10.
    Willats WGT. Phage display: practicalities and prospects. Plant Mol Biol. 2002;50:837–54.PubMedCrossRefGoogle Scholar
  11. 11.
    Smith GP. Surface presentation of protein epitopes using bacteriophage expression system. Curr Opin Biotechnol. 1991;2:668–73.PubMedCrossRefGoogle Scholar
  12. 12.
    Fack F, Deroo S, Kreis S, Muller CP. Heteroduplex mobility assay (HMA) pre-screening: an improved strategy for the rapid identification of inserts selected from phage-displayed peptide libraries. Mol Divers. 2000;5:7–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Kim YG, Lee CS, Chung WJ. Selection of peptides for lipopolysaccharide binding on to epoxy beads and selective detection of Gram-negative bacteria. Biotechnol Lett. 2006;28:79–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Zhao SW, Shen PP, Zhou Y, Wei Y, Xin XB, Hua ZC. Selecting peptide ligands of microcystin-LR from phage displayed random libraries. Environ Int. 2005;31:535–41.PubMedCrossRefGoogle Scholar
  15. 15.
    Zhang F, Yu M, Weiland E. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library. Arch Virol. 2006;151:37–54.PubMedCrossRefGoogle Scholar
  16. 16.
    Yu M, Than K, Colegate S, Shiell B, Michalski WP, Prowse S, Wang LF. Peptide mimotopes of phomopsins: identification, characterization and application in an immunoassay. Mol Divers. 2005;9:233–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Zang L, Shi L, Guo J, Pan Q, Wu W, Pan X. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library. Cancer Lett. 2009;18(281):64–70.CrossRefGoogle Scholar
  18. 18.
    Zaheer S, Wu YH, Bassett J. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res. 2007;32:2123–31.PubMedCrossRefGoogle Scholar
  19. 19.
    Eltayeb S, Berg AL, Lassmann H, Wallstrom E, Nilsson M, Olsson T, et al. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflamm. 2007;4:14.CrossRefGoogle Scholar
  20. 20.
    Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, et al. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J Neuroimmunol. 2002;128:16–22.PubMedCrossRefGoogle Scholar
  21. 21.
    Du B, Qian M, Zhou ZL. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Biophys Res Commun. 2006;34:2956–62.Google Scholar
  22. 22.
    Bratkovic T. Progress in phage display: evolution of the technique and its applications. Cell Mol Life Sci. 2009;67:749–67.CrossRefGoogle Scholar
  23. 23.
    Hitomi K, Kitamura M, Sugimura Y. Preferred substrate sequences for transglutaminase 2: screening using a phage-displayed peptide library. Amino Acids. 2009;36:619–24.PubMedCrossRefGoogle Scholar
  24. 24.
    Ransohoff RM, Bacon KB. Chemokine receptor antagonism as a new therapy for multiple sclerosis. Expert Opin Investig Drugs. 2000;95:1079–97.CrossRefGoogle Scholar
  25. 25.
    Liu NF, Wu GQ, Li H, et al. A novel peptide isolated from phage display peptides library recognized by an antibody against connective tissue growth factor (CTGF). Int Immunopharmacol. 2009;9:291–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel AG 2011

Authors and Affiliations

  • Hui-min Zheng
    • 1
  • Yun Jiang
    • 2
  • Ju-rong Wang
    • 1
  • Xue-lian Gong
    • 1
  • Bao-yu Guo
    • 1
  1. 1.Department of Biochemical Pharmacy, School of PharmacySecond Military Medical UniversityShanghaiPeople’s Republic of China
  2. 2.Department of Natural Medicinal Chemistry, School of PharmacySecond Military Medical UniversityShanghaiPeople’s Republic of China

Personalised recommendations